Literature DB >> 15222693

Discordant functional and inflammatory parameters in multiple sclerosis patients after autologous haematopoietic stem cell transplantation.

Kathleen M Healey1, Steven Z Pavletic, Jinan Al-Omaishi, M Patricia Leuschen, Samuel J Pirruccello, Mary L Filipi, Charles Enke, Mary Margaret Ursick, Francis Hahn, J D Bowen, Richard A Nash.   

Abstract

This article describes outcomes in four patients with advanced multiple sclerosis up to two years after autologous haematopoietic stem cell transplantation using a total-body irradiation-based preparative regimen. MRI and CSF analyses demonstrated clear suppression of the inflammatory processes. The results demonstrate however, a dissociation of inflammation parameters and functional disability findings raising questions about optimal future stem cell transplantation strategies for this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222693     DOI: 10.1191/1352458504ms1022oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  5 in total

1.  Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning.

Authors:  Su Ming Yvonne Loh; Pavanni Ratnagopal; Huat Chye Patrick Tan; Yeow Tee Goh; Boon Chai Mickey Koh; Liang Piu Koh; Yeh Ching Linn; William Ying Khee Hwang
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

Review 2.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.

Authors:  Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-04-28       Impact factor: 3.584

Review 3.  Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies.

Authors:  Abdolreza Ardeshiry Lajimi; Majid Farshdousti Hagh; Najmaldin Saki; Esmaeil Mortaz; Masoud Soleimani; Fakher Rahim
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

Review 4.  Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.

Authors:  Maria Teresa Cencioni; Angela Genchi; Gavin Brittain; Thushan I de Silva; Basil Sharrack; John Andrew Snowden; Tobias Alexander; Raffaella Greco; Paolo A Muraro
Journal:  Front Immunol       Date:  2022-02-01       Impact factor: 7.561

Review 5.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.